Categories

Bedfont® to showcase the innovative Smokerlyzer® and NObreath® respiratory devices at ERS 2025.

Bedfont® looks to expand European reach through new partnerships at the European Respiratory Society International Congress.

Bedfont® Scientific Limited, an innovative med-tech company with over 48 years of knowledge and expertise in the manufacture of medical breath analysis devices, are seeking new strategic distribution partners at this year's European Respiratory Society (ERS) Congress. On show will be the Smokerlyzer® and NObreath® devices. The Smokerlyzer® measures exhaled carbon monoxide (CO) to support smoking cessation efforts, while the NObreath® assesses Fractional exhaled Nitric Oxide (FeNO) levels to aid in the diagnosis and management of asthma.

The ERS Congress brings together respiratory experts from around the world to explore the latest advances inEanhUZiFON9XfJ1Nx16mydlmyAA0w9w5sjTyWoVr.png respiratory medicine and science. It takes place from September 27th to October 1st in Amsterdam, the Netherlands. This year's theme focuses on respiratory health around the globe, aligning perfectly with the Bedfont® vision of a world where everyone has access to instant, non-invasive, simple breath testing to aid in medical diagnosis.

“We’re thrilled to be part of this year’s ERS Congress and to present our Smokerlyzer® and NObreath® devices to the wider respiratory health community. These events are vital for sparking new ideas, forming strong industry partnerships, and advancing the field of respiratory diagnostics globally.” Said Jason Smith, CEO at Bedfont®.

Bedfont® work with a carefully selected network of over 100 distributors worldwide, chosen specifically on a foundation of shared values. The distributors, who are considered an extension of the Bedfont® Family, are fully supported and looked after throughout the partnership; through regular communication on essential updates, complete product training, comprehensive marketing resources, and complimentary educational content, including webinars hosted by Key Opinion Leaders (KOLs).

Je0I4yKj6A87ar2CZPAAOUgR3Qcjh2mtimAvwtWh.jpgAdditionally, distributors are invited to face-to-face events, with the most recent event being held in 2024. Bedfont® invited its extended family to the UK for a week of collaboration, including essential updates, in-person training, team-building activities, and distributor awards, with the in-person approach helping to build those crucial relationships.The friendly Bedfont® team can be found on stand D.13 at this year’s ERS congress. You are invited to stop by, say hello and receive demonstrations on the innovative Smokerlyzer® CO monitoring devices as well as the NObreath® FeNO device. For more information on these devices, visit the website here.

If you are interested in becoming a distributor of Bedfont® products, please visit the Become a Distributor page here.
Established in 1976, Bedfont® Scientific Limited is a second generation family company that has specialised in the design and manufacture of exhaled breath and gas monitoring instruments for medical, scientific and industrial markets globally, for over 40 years. Bedfont® is revered as a pioneer in the breath analysis market with their products now available in over 76 countries across the world thanks to their unprecedented network of appointed distributors. Their aim is to continue innovating and improving health worldwide.
Jemma Carter - jemma@bedfont.com | Communications and Content Coordinator

Contacts /

For more information, please contact:
Jemma Carter
Communications & Content Coordinator